IPCXR vs JCI · rev $100.0M vs P/E 44, rev $23.60B
Inflection Point Acquisition Corp. III Rights (IPCXR) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
IPCXR currently screens at market cap $0. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the IPCXR and JCI stock pages for the full models.
Not investment advice.